HR 5381 · 116th Congress · Health

International Pharmaceutical Transparency Act of 2019

Introduced 2019-12-10· Sponsored by Rep. DesJarlais, Scott [R-TN-4]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2019-12-11)

Plain Language Summary

[AI summary unavailable — showing source text] International Pharmaceutical Transparency Act of 2019 This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.…

Summarized by Claude AI · Non-partisan · For informational purposes only